Claims for Patent: 10,723,826
✉ Email this page to a colleague
Summary for Patent: 10,723,826
| Title: | Modifier for polycarbonate and method for producing same |
| Abstract: | Provided is a modifier for polycarbonate, comprising: a graft polymer (A) having 30 to 80 parts by mass of a main chain composed of an ethylene-based polymer (a) and 70 to 20 parts by mass of a graft chain composed of a structural unit derived from a vinyl-based monomer (b), with a total amount of the main chain and the graft chain of 100 parts by mass; and a graft polymer (B) prepared by graft polymerization of a vinyl-based monomer to a rubbery polymer, at a mass ratio (A):(B)=9 to 98:91 to 2, wherein the vinyl-based monomer (b) comprises a specific aromatic vinyl monomer and vinyl cyanide monomer. |
| Inventor(s): | Taisuke YUKAWA, Kazuhiro Ishigaki |
| Assignee: | Nippon A&L Inc |
| Application Number: | US15/928,552 |
Details for Patent 10,723,826
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | April 24, 2009 | 10,723,826 | 2038-03-22 |
| Janssen Biotech, Inc. | SIMPONI | golimumab | Injection | 125289 | May 15, 2013 | 10,723,826 | 2038-03-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,723,826
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2018273665 | ⤷ Get Started Free |
| Taiwan | I741167 | ⤷ Get Started Free |
| Taiwan | 201840696 | ⤷ Get Started Free |
| Poland | 3378879 | ⤷ Get Started Free |
| South Korea | 20180108480 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
